Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

NeuroSense Therapeutics Entered Into Capital On Demand Sales Agreement With JonesTrading Institutional Services; May Offer And Sell, From Time To Time, Ordinary Shares Of Up To Gross Sale Proceeds $2.5M

Author: Benzinga Newsdesk | August 16, 2024 04:14pm

- SEC Filing

Posted In: NRSN